Amyloid-PET as a diagnostic marker in daily practice. - ABIDE-PET

Vrije Universiteit Medisch Centrum0 个研究点目标入组 516 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•1) Patients of the VUmc Alzheimer Center with a written informed consent.;2) Patients of the UMC Utrecht who:
•a) visited the Centre of Vascular Cognitive Impairment or
•b) Parelsnoer participants.
•And were diagnosed with mild cognitieve impairment and provided a written informed consent.

•Patients who
•- are considered medically unstable (assessed by physician);
•- require additional laboratory tests or workup between enrollment and completion of the [18F]FBB PET scan;
•- are females of childbearing potential who are not surgically sterile, not refraining from sexual activity or not using reliable methods of contraception. Females of childbearing potential must not be pregnant or breast feeding at screening. Females must avoid becoming pregnant, and must agree to refrain from sexual activity or to use reliable contraceptive methods such as prescribed birth control or IUD for 24 hours following administration of [18F]FBB;
•- are not able to give informed consent (personally or via authorized person) for whatever reason.

发起方